Allergan wishes to extend their project portfolio in biopolymers for medical injectable and/or implantable applications through initiating new partnerships with academic or biotech partners.

Allergan is especially focused on structural proteins and biopolymers found in skin and soft tissues, such as:

  • Glycosaminoglycans (GAGs): hyaluronic acid, heparan sulfate, heparosan, dermatan sulfate, chitosan, chondroitin sulfate
  • Integrin extracellular ligands: collagen, elastin, polylysine, fibronectin, laminin, nidogens, osteopontin, …
  • Peptides: RGD peptides, Pal KTTKS, elastin-like peptide (ELP),…

Allergan is trying to identify projects related to such biopolymers and proteins for medical injectable and/or implantable applications.

They are looking for projects from preclinical stage (with an emphasis on in vivo projects) to recently marketed products.

If you believe that your organization could be a good fit, send a non-confidential summary of your work (slide deck preferred) to .

Find an actor

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

"Bristol-Myers Squibb to Acquire Celgene for About Billion"

"The combined company will have nine products with more than billion in annual sales"
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn